By 2026, the output value of nuclear medicine in Sichuan is expected to exceed 10 billion, accelerating the construction of a complete industrial chain map.

In the first half of this year, the GDP of Sichuan Province exceeded 3,362.9 billion yuan, with the added value of large-scale industrial strategic emerging industry enterprises growing by 7.6%. In the report card of emerging industries, the growth of nuclear medicine is particularly significant, with an expected output value of over 10 billion yuan by 2026. In a "chain leader" enterprise in the Jiajing Nuclear Technology Application Industrial Park, reporters learned that the production line here is currently preparing medical isotope lutetium-177, which will be shipped to six biopharmaceutical companies across the country in a few days.